Marco Iannone

ORCID: 0000-0002-1170-5570 · 1 paper in corpus · active 2023

Study types

  • other 1

Condition tags

  • endometriosis 1
other 2023
Molecules (Basel, Switzerland) ·doi:10.3390/molecules28093861

Elagolix sodium salt is the first marketed orally active non-peptide gonadotropin-releasing hormone receptor antagonist (GnRHR-ant) for the management of hormone dependent diseases, such as endometriosis and uterine fibroids. Despite its pr…